Search Results

There are 6067 results for: content related to: Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia

  1. You have free access to this content
    Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group

    Pediatric Blood & Cancer

    Volume 63, Issue 6, June 2016, Pages: 973–982, Uma H. Athale, Paul J. Gibson, Nicole M. Bradley, David M. Malkin and Johann Hitzler

    Version of Record online : 23 FEB 2016, DOI: 10.1002/pbc.25939

  2. The detection and significance of minimal residual disease in acute and chronic leukemia

    Tissue Antigens

    Volume 68, Issue 5, November 2006, Pages: 371–385, N.-G. Chung, V. Buxhofer-Ausch and J. P. Radich

    Version of Record online : 7 NOV 2006, DOI: 10.1111/j.1399-0039.2006.00714.x

  3. You have free access to this content
    Determination of minimal residual disease in leukaemia patients

    British Journal of Haematology

    Volume 121, Issue 6, June 2003, Pages: 823–838, Dario Campana

    Version of Record online : 3 JUN 2003, DOI: 10.1046/j.1365-2141.2003.04393.x

  4. You have free access to this content
    Status of minimal residual disease testing in childhood haematological malignancies

    British Journal of Haematology

    Volume 143, Issue 4, November 2008, Pages: 481–489, Dario Campana

    Version of Record online : 15 AUG 2008, DOI: 10.1111/j.1365-2141.2008.07350.x

  5. You have free access to this content
    Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation

    British Journal of Haematology

    Volume 162, Issue 2, July 2013, Pages: 147–161, Dario Campana and Wing Leung

    Version of Record online : 9 MAY 2013, DOI: 10.1111/bjh.12358

  6. You have free access to this content
    Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993

    British Journal of Haematology

    Volume 148, Issue 1, January 2010, Pages: 80–89, Bella Patel, Lena Rai, Georgina Buck, Sue M. Richards, Yeasmin Mortuza, Wayne Mitchell, Gareth Gerrard, Anthony V. Moorman, Veronique Duke, A. Victor Hoffbrand, Adele K. Fielding, Anthony H. Goldstone and Letizia Foroni

    Version of Record online : 26 OCT 2009, DOI: 10.1111/j.1365-2141.2009.07941.x

  7. You have free access to this content
    Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches

    British Journal of Haematology

    Volume 144, Issue 1, January 2009, Pages: 107–115, Jacqueline Ryan, Fiona Quinn, Armelle Meunier, Ludmila Boublikova, Mireille Crampe, Prerna Tewari, Aengus O’Marcaigh, Ray Stallings, Michael Neat, Ann O’Meara, Fin Breatnach, Shaun McCann, Paul Browne, Owen Smith and Mark Lawler

    Version of Record online : 11 NOV 2008, DOI: 10.1111/j.1365-2141.2008.07429.x

  8. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia

    British Journal of Haematology

    Volume 168, Issue 3, February 2015, Pages: 395–404, Rosemary Sutton, Peter J. Shaw, Nicola C. Venn, Tamara Law, Anuruddhika Dissanayake, Tatjana Kilo, Michelle Haber, Murray D. Norris, Chris Fraser, Frank Alvaro, Tamas Revesz, Toby N. Trahair, Luciano Dalla-Pozza, Glenn M. Marshall and Tracey A. O'Brien

    Version of Record online : 13 OCT 2014, DOI: 10.1111/bjh.13142

  9. You have free access to this content
    Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR

    British Journal of Haematology

    Volume 166, Issue 3, August 2014, Pages: 360–368, Sara Raponi, Irene Della Starza, Maria S. De Propris, Ilaria Del Giudice, Francesca R. Mauro, Marilisa Marinelli, Valeria Di Maio, Alfonso Piciocchi, Robin Foà and Anna Guarini

    Version of Record online : 16 APR 2014, DOI: 10.1111/bjh.12887

  10. You have free access to this content
    The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse

    Cytometry Part B: Clinical Cytometry

    Volume 76B, Issue 2, March 2009, Pages: 91–101, Adhra Al-Mawali, David Gillis and Ian Lewis

    Version of Record online : 25 AUG 2008, DOI: 10.1002/cyto.b.20444

  11. You have free access to this content
    Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now

    British Journal of Haematology

    Volume 134, Issue 3, August 2006, Pages: 273–282, Nick Goulden, Paul Virgo and David Grimwade

    Version of Record online : 29 JUN 2006, DOI: 10.1111/j.1365-2141.2006.06182.x

  12. You have free access to this content
    Detection of minimal residual disease in B lymphoblastic leukemia using viSNE

    Cytometry Part B: Clinical Cytometry

    Volume 88, Issue 5, September/October 2015, Pages: 294–304, Joseph A. DiGiuseppe, Michelle D. Tadmor and Dana Pe'er

    Version of Record online : 2 JUN 2015, DOI: 10.1002/cyto.b.21252

  13. You have free access to this content
    Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang

    British Journal of Haematology

    Volume 158, Issue 2, July 2012, Pages: 186–197, Estelle Gimenez, Martine Chauvet, Laetitia Rabin, Isabelle Puteaud, Samuel Duley, Sieme Hamaidia, Juliana Bruder, Valérie Rolland-Neyret, Steven Le Gouill, Olivier Tournilhac, Eric Voog, Hervé Maisonneuve, Marie C. Jacob, Dominique Leroux, Marie C. Béné, Christine Formisano-Tréziny, Jean Gabert, Rémy Gressin and Mary B. Callanan

    Version of Record online : 25 MAY 2012, DOI: 10.1111/j.1365-2141.2012.09161.x

  14. Effect of normal aging on the structure of marginal division of neostriatum as measured by MR phase imaging and diffusion tensor imaging

    Journal of Magnetic Resonance Imaging

    Zhiye Chen, Mengqi Liu, Mengyu Liu, Jinfeng Li, Han Shan, Shuangfeng Liu, Xin Lou, Siyun Shu and Lin Ma

    Version of Record online : 13 SEP 2016, DOI: 10.1002/jmri.25446

  15. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: A report from the Japanese Childhood Cancer and Leukemia Study Group

    Pediatric Blood & Cancer

    Volume 55, Issue 7, 15 December 2010, Pages: 1287–1295, Kazutaka Yamaji, Tomomi Okamoto, Shohei Yokota, Arata Watanabe, Yasuo Horikoshi, Keiko Asami, Atsushi Kikuta, Nobuyuki Hyakuna, Yutaka Saikawa, Junichi Ueyama, Tsutomu Watanabe, Masahiko Okada, Takashi Taga, Hirokazu Kanegane, Kazuhiro Kogawa, Motoaki Chin, Asayuki Iwai, Takeshi Matsushita, Yasuto Shimomura, Toshinori Hori, Masahito Tsurusawa and for The Japanese Childhood Cancer, Leukemia Study Group (JCCLSG)

    Version of Record online : 25 OCT 2010, DOI: 10.1002/pbc.22620

  16. Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia

    Cancer

    Elias Jabbour, Nicholas J. Short, Jeffrey L. Jorgensen, Musa Yilmaz, Farhad Ravandi, Sa A. Wang, Deborah A. Thomas, Joseph Khoury, Richard E. Champlin, Issa Khouri, Partow Kebriaei, Susan M. O'Brien, Guillermo Garcia-Manero, Jorge E. Cortes, Koji Sasaki, Courtney D. Dinardo, Tapan M. Kadia, Nitin Jain, Marina Konopleva, Rebecca Garris and Hagop Kantarjian

    Version of Record online : 7 SEP 2016, DOI: 10.1002/cncr.30264

  17. Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react

    British Journal of Haematology

    Volume 169, Issue 2, April 2015, Pages: 249–261, Cécile Pochon, Emmanuel Oger, Gérard Michel, Jean-Hugues Dalle, Alexandra Salmon, Brigitte Nelken, Yves Bertrand, Hélène Cavé, Jean-Michel Cayuela, Nathalie Grardel, Elizabeth Macintyre, Geneviève Margueritte, Françoise Méchinaud, Pierre Rohrlich, Catherine Paillard, François Demeocq, Pascale Schneider, Dominique Plantaz, Marilyne Poirée, Jean-François Eliaou, Gilbert Semana, Séverine Drunat, Philippe Jonveaux, Pierre Bordigoni and Virginie Gandemer

    Version of Record online : 19 DEC 2014, DOI: 10.1111/bjh.13272

  18. You have free access to this content
    Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia

    British Journal of Haematology

    Volume 146, Issue 3, August 2009, Pages: 292–299, Rosemary Sutton, Nicola C. Venn, Jonathan Tolisano, Anita Y. Bahar, Jodie E. Giles, Lesley J. Ashton, Lochie Teague, Gemma Rigutto, Keith Waters, Glenn M. Marshall, Michelle Haber, Murray D. Norris and Australian and New Zealand Children’s Oncology Group

    Version of Record online : 3 JUN 2009, DOI: 10.1111/j.1365-2141.2009.07744.x

  19. You have free access to this content
    Modelling a minimal residual disease-based treatment strategy in childhood acute lymphoblastic leukaemia

    British Journal of Haematology

    Volume 122, Issue 1, July 2003, Pages: 30–38, Peter J. Campbell and Alexander A. Morley

    Version of Record online : 20 JUN 2003, DOI: 10.1046/j.1365-2141.2003.04356.x

  20. Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia

    European Journal of Haematology

    Volume 96, Issue 3, March 2016, Pages: 276–284, Cyril Šálek, František Folber, Eva Froňková, Bohumír Procházka, Iuri Marinov, Petr Cetkovský, Jiří Mayer, Michael Doubek and Czech Leukemia Study Group - for Life (CELL)

    Version of Record online : 22 JUN 2015, DOI: 10.1111/ejh.12587